Frontiers in Oncology (Nov 2022)

Impact of intestinal dysbiosis on breast cancer metastasis and progression

  • Jin Zhang,
  • Qiqi Xie,
  • Xingfa Huo,
  • Zhilin Liu,
  • Mengting Da,
  • Mingxue Yuan,
  • Yi Zhao,
  • Guoshuang Shen

DOI
https://doi.org/10.3389/fonc.2022.1037831
Journal volume & issue
Vol. 12

Abstract

Read online

Breast cancer has a high mortality rate among malignant tumors, with metastases identified as the main cause of the high mortality. Dysbiosis of the gut microbiota has become a key factor in the development, treatment, and prognosis of breast cancer. The many microorganisms that make up the gut flora have a symbiotic relationship with their host and, through the regulation of host immune responses and metabolic pathways, are involved in important physiologic activities in the human body, posing a significant risk to health. In this review, we build on the interactions between breast tissue (including tumor tissue, tissue adjacent to the tumor, and samples from healthy women) and the microbiota, then explore factors associated with metastatic breast cancer and dysbiosis of the gut flora from multiple perspectives, including enterotoxigenic Bacteroides fragilis, antibiotic use, changes in gut microbial metabolites, changes in the balance of the probiotic environment and diet. These factors highlight the existence of a complex relationship between host-breast cancer progression-gut flora. Suggesting that gut flora dysbiosis may be a host-intrinsic factor affecting breast cancer metastasis and progression not only informs our understanding of the role of microbiota dysbiosis in breast cancer development and metastasis, but also the importance of balancing gut flora dysbiosis and clinical practice.

Keywords